entity

therapeutic window

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about therapeutic window: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections
24Hypotheses
6Analyses
0Outgoing
5Incoming
3Experiments
9Debates

No AI portrait yet

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (5)

SourceRelationTypeStr
protective chromatin remodelingtherapeutic_target_forpathway0.70
Neurons retain ketone oxidation capacitybiomarker_forprocess0.70
astrocytic ketone production declinecausesprocess0.70
neuronal ketone oxidation capacityassociated_withprocess0.70
Nrf2 activationmodulatespathway0.70

Targeting Hypotheses (24)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
CSF sTREM2 as Pharmacodynamic Biomarker for Therapeutic Wind 0.801 neuroimmunology TREM2 in Alzheimer's Disease: Mechanisms
Integrated Biomarker Panel for Therapeutic Window Identifica 0.784 neurodegeneration What are the precise temporal dynamics o
Sleep-Dependent Glymphatic Clearance Expands the Therapeutic 0.780 neurodegeneration What is the therapeutic window between t
Therapeutic Window Exists Because Amplified Signals (Not Bas 0.780 neurodegeneration Do pathogenic LRRK2 mutations amplify vo
Conformational-Selective Blocking of Tau Uptake Reveals Ther 0.710 neurodegeneration What is the therapeutic window between t
TREM2-Dependent Microglial State Transition as Therapeutic W 0.690 neurodegeneration Gap 006 analysis (archived stub)
BBB Integrity Loss Defines Absolute Therapeutic Window Closu 0.660 neurodegeneration What is the optimal therapeutic window f
Critical Period Hypothesis: The Therapeutic Window Closes Wh 0.640 neurodegeneration What is the therapeutic window between t
Autophagy-Senescence Axis Therapeutic Window 0.624 - Senescent cell clearance as neurodegener
Glial-Autophagy-Senescence Coupling Defines CNS Therapeutic 0.614 molecular biology What is the optimal therapeutic window t
G3BP1 Haploinsufficiency Reveals a Therapeutic Window for SG 0.590 neurodegeneration How do disease-associated mutations in G
Conserved G-Quadruplex Forming Potential in HOTAIR Defines T 0.568 molecular biology What are the conserved secondary structu
Therapeutic Window Exists Through Activity-Dependent Regulat 0.520 neurodegeneration What is the therapeutic window between t
Cerebrospinal NFL-Triggered Liposome Dosing Maximizes lncRNA 0.517 molecular neurobiology View
CSF Neurofilament Light-Triggered Astrocyte-Derived Exosome 0.450 molecular neurobiology View
Autophagy-Lysosomal Clearance Capacity Determines Therapeuti 0.380 protein folding Can chaperone enhancement approaches ove
Lysosomal Clearance Capacity Determines Therapeutic Window—A 0.380 protein folding Can chaperone enhancement approaches ove
endothelial transcytosis defines the therapeutic window for: 0.357 neurodegeneration Blood-brain barrier permeability changes
protective chromatin remodeling defines the therapeutic wind 0.345 neurodegeneration Are DNA methylation changes in neurodege
microglial inflammasome tone defines the therapeutic window 0.341 neurodegeneration How does gut microbiome dysbiosis contri
CHMP2B vs. CHMP2A Subunit Targeting Creates a Therapeutic Wi 0.330 neurodegeneration What is the therapeutic window between t
proteasome shuttle failure defines the therapeutic window fo 0.327 neurodegeneration How do ALS-linked UBQLN2 mutations affec
protective chromatin remodeling defines the therapeutic wind 0.326 neurodegeneration Are age-related DNA methylation changes
Plasma p-tau217-Triggered Exosome Dosing Maximizes lncRNA-00 0.323 molecular neurobiology View

Mentioning Analyses (6)

Scientific analyses that reference this entity

Are DNA methylation changes in neurodegeneration causal drivers or protective co

neurodegeneration | 2026-04-26 | 3 hypotheses Top: 0.345

Does TRPML1 enhancement cause therapeutic benefit or paradoxical lysosomal dysfu

neurodegeneration | 2026-04-16 | 2 hypotheses Top: 0.575

What are the precise temporal dynamics of astrocyte ketone production decline du

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.808

Why do p300/CBP inhibitors reduce both AD incidence and clinically diagnosed TBI

neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.604

Do P2RX7 antagonists selectively block pathogenic exosomes while preserving bene

neurodegeneration | 2026-04-11 | 0 hypotheses

Experiments (3)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Autophagy receptor identification for stress granule elimination exploratory neurodegenerative diseases 0.900 0.00 cultured cells under arsenite proposed N/A
Chi3l1 deletion effects on baseline glial activation in mice validation baseline neuroinflammation 0.900 0.00 Chi3l1 knockout mice proposed N/A
CHI3L1 variant association with AD progression in human patients exploratory Alzheimer's disease 0.850 0.00 human patients proposed N/A

Related Papers (19)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis [PMID:40771159] Padilla CM, Lafyatis R, Gibson KF, Morse Arthritis Care Res (Hoboken) 2026 0
Obstructive sleep apnea, biomarker profiles, and clinical progression in Parkins [PMID:41499940] Zhu S, An D, Liu X Sleep Med 2026 0
SuPAR levels are increased in sera of euthymic patients with bipolar disorder an [PMID:41605346] Kök Kendirlioğlu B, Çörekli Kaymakçı E, J Affect Disord 2026 0
Chitinase-like Proteins YKL-40 and YKL-39 in Colorectal Cancer. [PMID:41677627] Ivanova T, Kazakova M, Dikov D, Dzhambov Cells 2026 0
Correction: CHI3L1: An Emerging Player in Neuroinflammation and Neurodegeneratio [PMID:41699333] Mushtaq Umar; Seh Bilal Ahmad; Khanday F Molecular Neurobiology 2026 0
Association of Alzheimer's disease progression with YKL40 levels in peripheral b [PMID:41725729] Yang Q, Wang R, Pei J, Fu Q, Zhan Y et a Front Neurol 2026 0
Constitutive neuronal expression and disease-associated upregulation of chitinas [PMID:41762671] Gaur N, Angerer C, Gunes ZI, Ancau M, Wa Brain 2026 0
Plasma CHI3L1 as a marker of cognitive and structural brain changes in radiologi [PMID:41953284] Schneider R, Brand-Arzamendi K, Lim TR, BMJ Neurol Open 2026 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Targeting SARM1 improves autophagic stress-induced axonal neuropathy. [PMID:37561040] Kim HR, Lee HJ, Jeon Y, Jang SY, Shin YK Autophagy 2024 0
Neurodegeneration and demyelination in multiple sclerosis. [PMID:38889714] Garton T, Gadani SP, Gill AJ, Calabresi Neuron 2024 0
STING orchestrates the neuronal inflammatory stress response in multiple scleros [PMID:38878778] Woo MS, Mayer C, Binkle-Ladisch L, Sonne Cell 2024 0
Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration. [PMID:36917977] Neel DV, Basu H, Gunner G, Bergstresser Neuron 2023 0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] Marogianni C, Sokratous M, Dardiotis E, International journal of molec 2020 0
PLA2G4A/cPLA2-mediated lysosomal membrane damage leads to inhibition of autophag [PMID:31238788] ["Sarkar Chinmoy", "Jones Jace W", "Hegd Autophagy 2020 0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] Marogianni C, Sokratous M, Dardiotis E, International journal of molec 2020 0
Multiple Sclerosis Pathology. [PMID:29358320] Lassmann H Cold Spring Harbor perspective 2018 0
Calcium and neurodegeneration. [PMID:17328689] Mattson MP Aging cell 2007 0

Debates (9)

Multi-agent debates referencing this entity

Formal debate: age-linked CpG drift is the actionable driver in: Are DNA methyla

closed · Rounds: 3 · Score: 0.75 · 2026-04-26

Formal debate: ATAC-seq accessibility separates causal from compensatory states

closed · Rounds: 3 · Score: 0.75 · 2026-04-26

Are DNA methylation changes in neurodegeneration causal drivers or protective co

closed · Rounds: 4 · Score: 0.78 · 2026-04-26

The debate revealed conflicting evidence about whether TRPML1 activation rescues

closed · Rounds: 4 · Score: 0.72 · 2026-04-21

The debate highlighted P2RX7's dual role in both harmful exosome secretion and b

closed · Rounds: 4 · Score: 1.00 · 2026-04-20

The debate revealed conflicting evidence about whether TRPML1 activation rescues

closed · Rounds: 4 · Score: 0.46 · 2026-04-16

The observation that salsalate and diflunisal decrease both AD and TBI incidence

closed · Rounds: 4 · Score: 0.95 · 2026-04-16

The debate identified a critical therapeutic window when astrocytic ketone produ

closed · Rounds: 4 · Score: 0.85 · 2026-04-15

How do astrocyte-neuron metabolic interactions change during disease progression

closed · Rounds: 4 · Score: 0.93 · 2026-04-04

Related Research

Hypotheses and analyses mentioning therapeutic window in their description or question text

TREM2-Dependent Microglial State Transition as Therapeutic Window in Alzheimer's

Score: 0.690 · neurodegeneration · 2026-04-22

## Mechanistic Overview TREM2-Dependent Microglial State Transition as Therapeutic Window in Alzheimer's Disease starts

BBB Integrity Loss Defines Absolute Therapeutic Window Closure

Score: 0.660 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The blood-brain barrier (BBB) represents a highly specialized neurovascular inter

Critical Period Hypothesis: The Therapeutic Window Closes When Neuronal Homeosta

Score: 0.640 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The critical period hypothesis centers on the premise that neuronal homeostasis o

Autophagy-Senescence Axis Therapeutic Window

Score: 0.624 · unknown disease · 2026-04-16

## Mechanistic Overview Autophagy-Senescence Axis Therapeutic Window starts from the claim that modulating ATG7,BCL2,BCL

Glial-Autophagy-Senescence Coupling Defines CNS Therapeutic Windows

Score: 0.614 · molecular biology · 2026-04-21

## Mechanistic Overview Glial-Autophagy-Senescence Coupling Defines CNS Therapeutic Windows starts from the claim that m

G3BP1 Haploinsufficiency Reveals a Therapeutic Window for SG-Targeting Intervent

Score: 0.590 · neurodegeneration · 2026-04-22

## Mechanistic Overview G3BP1 Haploinsufficiency Reveals a Therapeutic Window for SG-Targeting Interventions starts from

Conserved G-Quadruplex Forming Potential in HOTAIR Defines Therapeutic Window

Score: 0.568 · molecular biology · 2026-04-21

## Mechanistic Overview Conserved G-Quadruplex Forming Potential in HOTAIR Defines Therapeutic Window starts from the cl

Therapeutic Window Exists Through Activity-Dependent Regulation of Synaptic Vesi

Score: 0.520 · neurodegeneration · 2026-04-22

## Mechanistic Overview Therapeutic Window Exists Through Activity-Dependent Regulation of Synaptic Vesicle Priming star

Cerebrospinal NFL-Triggered Liposome Dosing Maximizes lncRNA-0021 Therapeutic Wi

Score: 0.517 · molecular neurobiology · 2026-04-20

## Mechanistic Overview Cerebrospinal NFL-Triggered Liposome Dosing Maximizes lncRNA-0021 Therapeutic Window in AD start

CSF Neurofilament Light-Triggered Astrocyte-Derived Exosome Dosing Maximizes lnc

Score: 0.450 · molecular neurobiology · 2026-04-21

## Mechanistic Overview CSF Neurofilament Light-Triggered Astrocyte-Derived Exosome Dosing Maximizes lncRNA-0021 Therape

Autophagy-Lysosomal Clearance Capacity Determines Therapeutic Window—Substrate C

Score: 0.380 · protein folding · 2026-04-27

**Molecular Mechanism and Rationale** This therapeutic hypothesis targets the autophagy-lysosomal degradation pathway's

Lysosomal Clearance Capacity Determines Therapeutic Window—Autophagy Enhancement

Score: 0.380 · protein folding · 2026-04-26

The therapeutic hypothesis centers on the kinetic constraints governing autophagy-lysosomal degradation of pathological

endothelial transcytosis defines the therapeutic window for: Blood-brain barrier

Score: 0.357 · neurodegeneration · 2026-04-26

The same signal may be beneficial early and damaging late. Testing endothelial transcytosis with pericyte-protective dos

protective chromatin remodeling defines the therapeutic window for: Are DNA meth

Score: 0.345 · neurodegeneration · 2026-04-26

The same signal may be beneficial early and damaging late. Testing protective chromatin remodeling with single-cell meth

microglial inflammasome tone defines the therapeutic window for: How does gut mi

Score: 0.341 · neurodegeneration · 2026-04-26

The same signal may be beneficial early and damaging late. Testing microglial inflammasome tone with dietary fiber chall